Multiple Sclerosis (MS) Drug Market

RECENT NEWS
MedPage Today  Nov 19  Comment 
(MedPage Today) -- Research community has progressive multiple sclerosis in its sights.
FierceBiotech  Nov 15  Comment 
Late on Friday the FDA put out the word that it has reversed its earlier decision against Sanofi's multiple sclerosis drug Lemtrada, agreeing to allow the pharma giant the right to market the treatment--with some tight controls on just who will...
MedPage Today  Nov 15  Comment 
(MedPage Today) -- Multiple sclerosis drug is given annually.
Bloomberg  Nov 13  Comment 
Merck KGaA Raises 2014 Forecast as Sales of Rebif Climb Merck KGaA raised its sales forecast for the year as the German chemical and drug maker’s multiple- sclerosis...
GenEng News  Nov 1  Comment 
In 1977, when researchers published the genome of bacteriophage PhiX174, the first fully sequenced virus, about 1,000 base pairs could be sequenced within a year. Researchers estimated that if they were to keep using the same sequencing...
FiercePharma  Oct 30  Comment 
Sales of Teva's multiple sclerosis drug, Copaxone, are still growing--at least for now. The Israeli company's top-seller, whose patent is currently the subject of a Supreme Court appeal, ticked up 5% to reach $1.1 billion in Q3 sales.
GenEng News  Oct 1  Comment 
The demand for peptides as active pharmaceutical ingredients (APIs) is continuously increasing because they are highly active, highly specific, and metabolically favorable substances. Peptides perform diverse physiological functions, and thus are...
GenEng News  Sep 30  Comment 
Patients with multiple sclerosis (MS) were able to safely tolerate treatment with cells cultured from human placental tissue, according to an article (“Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: A...
newratings.com  Sep 24  Comment 
HAMBURG (dpa-AFX) - Evotec AG (EVTCY.PK, EVOTF.PK) a German drug discovery and development company, announced Wednesday that it has entered into three novel research projects for the treatment of Multiple Sclerosis or MS supported by research...
MedPage Today  Sep 18  Comment 
BOSTON (MedPage Today) -- Multiple sclerosis patients with larger intracranial volumes -- a measure of their lifetime maximal brain size -- scored better on cognition and physical function tests than those with smaller skull sizes.




 
TOP CONTRIBUTORS

Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki